My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 3 results for

GO
Search Filters: Massachusetts cancel Indiana cancel Social and Behavioral Health cancel Blog cancel

How States Can Leverage JUUL Settlement Funds to Promote Public Health

Health Policy Update,
Tobacco Control,
Funding,
Federal Government Affairs,
State Health Policy,
Territorial Health Policy,
Arizona,
California,
Colorado,
Connecticut,
Illinois,
Indiana,
Iowa,
Massachusetts,
Minnesota,
Mississippi,
New Mexico,
New York,
North Carolina,
Pennsylvania,
Puerto Rico,
Washington, D.C.,
Amy Ciarlo,
Matta Sannoh

To address the youth tobacco epidemic, jurisdictions filed lawsuits against JUUL to end their marketing practices aimed at youth and to obtain compensation from the financial toll experienced by ...

Stronger Together: Six Strategies to Enhance Your State’s Suicide Prevention Infrastructure

Health Policy Update,
COVID and Mental Health,
Mental Health,
Suicide Prevention,
Social Determinants of Health,
At-Risk Populations,
State Health Policy,
Indiana,
Massachusetts,
Minnesota,
Nevada,
Ohio,
Utah,
Partnership,
Julia Wunder,
Julie Ebin,
Public Health Infrastructure and Systems Improvement

May is Mental Health Awareness Month and the importance of continued mental health promotion and suicide prevention efforts during the COVID-19 pandemic. As we address the physical effects of ...

How the Emergence of Xylazine Impacts Overdose Prevention Policy

State Health Policy,
Overdose Prevention,
Alaska,
Colorado,
Guam,
Maine,
Maryland,
Nebraska,
New York,
Northern Mariana Islands,
Pennsylvania,
South Carolina,
Vermont,
Illinois,
New Hampshire,
Delaware,
New Jersey,
Florida,
Massachusetts,
Utah,
Michigan,
Rhode Island,
Oklahoma,
West Virginia,
Indiana,
Puerto Rico,
JoAnne McClure,
Victoria Pless,
Health Policy Update,
Ohio

How the Emergence of Xylazine Impacts Overdose Prevention Policy overdose prevention policy, overdose crisis, fatal overdoses, emergence of xylazine, illicit drug supply, toxicological testing, ...